1. Ancient Greek and Greco–Roman Methods in Modern Surgical Treatment of Cancer

   • Niki Papavramidou
   • Theodossis Papavramidis
   • Thespis Demetriou

   Breast Oncology Open access 05 January 2010 Pages: 665 - 667

2. The Marriage Between Pathology and Genetics: Are We Ready for Clinical Use?

   • Angelo P. Dei Tos

   Bone and Soft Tissue Sarcomas Open access 04 December 2009 Pages: 668 - 669

3. Who Is to Blame for False-Negative Sentinel Node Biopsies in Melanoma?

   • Vernon K. Sondak
   • Jonathan S. Zager

   Melanomas Open access 02 December 2009 Pages: 670 - 673

4. Computer-Based Learning Module and the Educational Process for Women with Breast Cancer Who Desire Reconstruction

   • Albert Losken

   Reconstructive Oncology Open access 29 December 2009 Pages: 674 - 675

5. Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?

   • Luis J. Herrera

   Thoracic Oncology Open access 02 December 2009 Pages: 676 - 678

6. The Value of Intraoperative Parathyroid Hormone Monitoring in Localized Primary Hyperparathyroidism: A Cost Analysis

   • Lilah F. Morris
   • Kyle Zanocco
   • Michael W. Yeh

   Healthcare Policy and Outcomes Open access 03 November 2009 Pages: 679 - 685

   

7. Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience

   • Ronald S. A. de Vreeze
   • Daphne de Jong
   • Frits van Coevorden

   Bone and Soft Tissue Sarcomas Open access 19 November 2009 Pages: 686 - 693

   

8. Primary Malignant Giant-Cell Tumor of Bone Has High Survival Rate

   • Stepan V. Domovitov
   • John H. Healey

   Bone and Soft Tissue Sarcomas 10 November 2009 Pages: 694 - 701

   

9. Differential Presentations, Clinical Courses, and Survivals of Osteosarcomas of the Proximal Humerus over Other Extremity Locations

   • Wan Hyeong Cho
   • Won Seok Song
   • Soo-Yong Lee

   Bone and Soft Tissue Sarcomas 17 November 2009 Pages: 702 - 708

   

10. Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients

    • Charles R. Scoggins
    • Robert C. G. Martin
    • Kelly M. McMasters

    Melanomas 05 December 2009 Pages: 709 - 717

    

11. Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma

    • Howard L. Kaufman
    • Dae Won Kim
    • Seunghee Kim-Schulze

    Melanomas 14 November 2009 Pages: 718 - 730

    

12. Feasibility of a Novel Approach to Inguinal Lymphadenectomy: Minimally Invasive Groin Dissection for Melanoma

    • Keith A. Delman
    • David A. Kooby
    • Viraj Master

    Melanomas 17 November 2009 Pages: 731 - 737

    

13. Computer-Based Learning Module Increases Shared Decision Making in Breast Reconstruction

    • Bernard T. Lee
    • Chen Chen
    • Adam M. Tobias

    Reconstructive Oncology 29 December 2009 Pages: 738 - 743

    

14. Predictive Factors of Response to Decongestive Therapy in Patients with Breast-Cancer-Related Lymphedema

    • Isabel Forner-Cordero
    • José Muñoz-Langa
    • Juan M. DeMiguel-Jimeno

    Breast Oncology 27 October 2009 Pages: 744 - 751

15. Obesity and Angiolymphatic Invasion in Primary Breast Cancer

    • Erin F. Gillespie
    • Melony E. Sorbero
    • Jennifer J. Griggs

    Breast Oncology 07 November 2009 Pages: 752 - 759

16. Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk

    • Ming-Shiean Hsu
    • Jyh-Cherng Yu
    • Chun-Wen Cheng

    Breast Oncology 21 November 2009 Pages: 760 - 771

17. Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence

    • Sonia Pernas
    • Marta Gil
    • Miguel Gil Gil

    Breast Oncology 14 November 2009 Pages: 772 - 777

    

18. Ductoscopy in the Evaluation and Management of Nipple Discharge

    • Sedat Kamali
    • Ömer Bender
    • Gülçin Kamalı

    Breast Oncology 11 December 2009 Pages: 778 - 783

    

19. How Does the Number of Resected Lymph Nodes Influence TNM Staging and Prognosis for Esophageal Carcinoma?

    • Yang Hu
    • Chunyan Hu
    • Long-Qi Chen

    Thoracic Oncology 02 December 2009 Pages: 784 - 790

    

20. The Roles of Neoadjuvant Radiotherapy and Lymphadenectomy in the Treatment of Esophageal Adenocarcinoma

    • Naveenraj Solomon
    • Ying Zhuge
    • Leonidas G. Koniaris

    Thoracic Oncology 02 December 2009 Pages: 791 - 803

    

21. p53 Mutation Status Predicts Pathological Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer

    • Tomoki Makino
    • Makoto Yamasaki
    • Yuichiro Doki

    Thoracic Oncology 03 November 2009 Pages: 804 - 811

    

22. A Critical Appraisal of Circumferential Resection Margins in Esophageal Carcinoma

    • Bareld B. Pultrum
    • Judith Honing
    • John Th. M. Plukker

    Gastrointestinal Oncology Open access 19 November 2009 Pages: 812 - 820

    

23. KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer

    • Takeshi Yokoe
    • Yuji Toiyama
    • Masato Kusunoki

    Gastrointestinal Oncology 07 November 2009 Pages: 821 - 828

    

24. Clinicopathological Features and Prognostic Factors of Proximal Gastric Carcinoma in a Population with High Helicobacter pylori Prevalence: A Single-Center, Large-Volume Study in Korea

    • Jun Chul Park
    • Yong Chan Lee
    • Choong Bai Kim

    Gastrointestinal Oncology 31 October 2009 Pages: 829 - 837

    

25. Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment?

    • Raffaele Lombardi
    • Dajana Cuicchi
    • Bruno Cola

    Colorectal Cancer 12 December 2009 Pages: 838 - 845

26. The Adrenal Mass: Correlation of Histopathology with Imaging

    • Linwah Yip
    • Mitchell E. Tublin
    • John H. Yim

    Endocrine Tumors 04 December 2009 Pages: 846 - 852

27. Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma

    • J. Alejandro Rauh-Hain
    • Alexander B. Olawaiye
    • Linda Duska

    Gynecologic Oncology 18 November 2009 Pages: 853 - 860

    

28. The Role of Pelvic and/or Para-Aortic Lymphadenectomy in Surgical Management of Apparently Early Carcinosarcoma of Uterus

    • Jeong-Yeol Park
    • Dae-Yeon Kim
    • Joo-Hyun Nam

    Gynecologic Oncology 18 November 2009 Pages: 861 - 868

    

29. Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection

    • Ju Hyun Shim
    • Kang Mo Kim
    • Dong Jin Suh

    Hepatobiliary Tumors 22 December 2009 Pages: 869 - 877

    

30. Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling

    • Makoto Suzuki
    • Hironobu Wada
    • Ichiro Yoshino

    Translational Research and Biomarkers 16 October 2009 Pages: 878 - 888

    

31. Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene

    • Tsuyoshi Takahashi
    • Makoto Sonobe
    • Hiroshi Date

    Translational Research and Biomarkers 21 November 2009 Pages: 889 - 897

    

32. Hypoxic Single-Pass Isolated Hepatic Perfusion of Hypotonic Cisplatin: Safety Study in the Pig

    • Pablo Ortega-Deballon
    • Olivier Facy
    • Bruno Chauffert

    Translational Research and Biomarkers 27 October 2009 Pages: 898 - 906

    

33. CKS1B Overexpression Implicates Clinical Aggressiveness of Hepatocellular Carcinomas but Not p27^Kip1 Protein Turnover: an Independent Prognosticator with Potential p27^Kip1-Independent Oncogenic Attributes?

    • Ching-Wen Huang
    • Ching-Yih Lin
    • Yow-Ling Shiue

    Translational Research and Biomarkers 29 October 2009 Pages: 907 - 922

    

34. Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis

    • Shuji Nomoto
    • Mitsuro Kanda
    • Akimasa Nakao

    Translational Research and Biomarkers 07 November 2009 Pages: 923 - 932

    

35. Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer: Is It of Clinical Value?

    • Dimosthenis Ziogas
    • Haralampos Harissis
    • Charalabos Batsis

    Breast Oncology 15 October 2009 Pages: 933 - 934

36. Reply to: Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer

    • Masahiro Sakakibara
    • Takeshi Nagashima
    • Masaru Miyazaki

    Breast Oncology 15 October 2009 Pages: 935 - 935

37. Micrometastatic Sentinel Lymph Node Disease: Do Patients Benefit or Suffer Harm from Axillary Lymph Node Dissection?

    • D. Ziogas
    • G. C. Zografos

    Breast Oncology 25 November 2009 Pages: 936 - 937

38. In Reply: Micrometastases in Breast Cancer Sentinel Lymph Node

    • Ulrich Guller
    • Igor Langer
    • Markus Zuber

    Breast Oncology 10 December 2009 Pages: 938 - 938

39. Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery

    • G. C. Zografos
    • D. H. Roukos

    Breast Oncology 24 November 2009 Pages: 939 - 939

40. Author Reply: Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery

    • Amanda Arrington
    • Todd Tuttle

    Breast Oncology 24 November 2009 Pages: 940 - 940

41. Follow-Up for Gastric Cancer: How Extensive and Intensive Should It Be?

    • C. Bali
    • D. H. Roukos
    • D. E. Ziogas

    Gastrointestinal Oncology 04 December 2009 Pages: 941 - 941

42. Author Reply: Follow-Up for Gastric Cancer: How Extensive and Intensive Should It Be?

    • Hoon Hur
    • Kyo Young Song
    • Hae Myung Jeon

    Gastrointestinal Oncology 10 December 2009 Pages: 942 - 942

43. Stage and Microscopic Positive Margins in the Treatment of Patients with Gastric Cancer

    • Zhe Sun
    • Hui-mian Xu

    Letter to the Editor 29 December 2009 Pages: 943 - 945

44. Emphasis on Preventing Microscopic Positive Margins in Gastric Cancer

    • J. Spiliotis

    Gastrointestinal Oncology 21 January 2010 Pages: 946 - 946